Biopharma returns to MC4R for drugs targeting genetic obesity as well as appetite lossnews2025-08-28T11:00:44+00:00August 28th, 2025|Endpoints News|
Protein degrader startup Plexium raises $60M after Amgen pact endednews2025-08-28T10:44:44+00:00August 28th, 2025|Endpoints News|
Lilly pauses Mounjaro orders in the UK just before raising its price news2025-08-28T10:32:52+00:00August 28th, 2025|Endpoints News|
CDC Director Susan Monarez suddenly departs weeks into the rolenews2025-08-27T22:19:50+00:00August 27th, 2025|Endpoints News|
Exelixis to close Pennsylvania site, lay off 130 staffersnews2025-08-27T19:07:09+00:00August 27th, 2025|Endpoints News|
FDA talks limitations, potential for cancer registriesnews2025-08-27T18:11:55+00:00August 27th, 2025|Endpoints News|
Indivior to reduce headcount, real estate in first stage of broader reorgnews2025-08-27T15:28:19+00:00August 27th, 2025|Endpoints News|
Verzenio’s survival benefit in early breast cancer; Another RemeGen Phase 3 winnews2025-08-27T14:48:23+00:00August 27th, 2025|Endpoints News|
Amylyx’s old ALS drug fails in another neuro disease, focus turns to GLP-1news2025-08-27T14:47:29+00:00August 27th, 2025|Endpoints News|
